Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
CRWV$48.04+4.49(+10.31%)A Wall Street Mystery Seller Is Now Trying to Dump $500 Million of Data Center Loans7:43:33 AM ETGOOGL$281.28-1.32(-0.47%)UPDATE 2-Alphabet takes $548 million stake in partner Qualcomm in data center push7:42:43 AM ETPEP$139.16-3.61(-2.53%)If You Invested $300,000 in Coca-Cola, PepsiCo and Keurig Dr Pepper, Here's What They'd Pay7:37:28 AM ETNVDA$188.60+7.01(+3.86%)Nvidia Just Had Its Worst Day Since DeepSeek, Losing About $450 Billion7:37:04 AM ETCMCSA$24.15-0.83(-3.32%)UPDATE 1-UK broadcaster Sky received security threat, as alerts sweep Europe7:35:58 AM ETMRNA$252.92+11.72(+4.86%)Moderna Lifts Full-Year Outlook, Swings to Quarterly Profit7:34:00 AM ETPLTR$158.73+3.82(+2.47%)Prediction: $5,000 Invested in Palantir Will Be Worth This Much by 20317:33:00 AM ETBN$41.74-0.02(-0.05%)Brookfield Asset Management Fundraises $25 Billion in Quarter, Led by Infrastructure Strategies7:30:00 AM ETCMCSA$24.15-0.83(-3.32%)UK broadcaster Sky says it received security threat7:28:07 AM ETMMM$186.35-1.42(-0.76%)3M: Strong Order Momentum And Improving Execution Point To More Upside7:25:39 AM ETEQIX$1,001.00+3.65(+0.37%)Wall Street's Loudest Voices Split on Whether the AI Trade Is Finished7:22:47 AM ETTGT$155.35-2.58(-1.63%)Own Target Stock by Nov. 9 to Qualify for Its Dec. 1 Dividend. Here's How Many Shares of the Dividend King You'd Need for $2,000 in Yearly Dividends.7:22:00 AM ETKO$94.09-1.78(-1.86%)Coca-Cola Has Raised Its Dividend for 64 Straight Years. Here's What $10,000 Will Pay You in 2027.7:22:00 AM ETTSLA$349.34+6.02(+1.75%)Tesla and SpaceX Have Lost $457 Billion in Two Days7:21:49 AM ETLLY$1,352.02-15.08(-1.10%)BRIEF-Eli Lilly & Hims & Hers Health Announce Agreement To Expand Access To Zepbound & Foundayo7:20:47 AM ETMRNA$252.92+11.72(+4.86%)BRIEF-Moderna Expects Total Revenue Growth Of 15% To 25% In 20267:18:41 AM ETEGP$193.86-7.14(-3.55%)These Warehouse REITs Are Riding the E-Commerce Boom. Which Pays the Safest Dividend?7:17:09 AM ETWEST$9.54-0.82(-7.92%)What Westrock Coffee (WEST) Said on Its Q3 Earnings Call7:16:59 AM ETTSX:ENB$67.33-0.69(-1.01%)Canada's Enbridge Q3 EBITDA rises on higher gas transmission, distribution rates7:16:38 AM ETTSX:ENB$67.33-0.69(-1.01%)UPDATE 1-Enbridge's quarterly profit rises on strength in natural gas businesses7:16:06 AM ETPLTR$158.73+3.82(+2.47%)Palantir Shed Nearly 20% Over 12 Months: This Wall Street Desk Predicts 76% Gains Moving Forward7:15:57 AM ETBAM$53.90+1.44(+2.74%)Brookfield Asset Management Q3 fee-related earnings rise on Oaktree acquisition7:15:42 AM ETAAPL$339.98-4.42(-1.28%)Apple Is Virtually Insulated From Blue-Wave Pain Points7:15:30 AM ETAAPL$339.98-4.42(-1.28%)Apple Vs. Alphabet: The Midterms Just Separated Them from The Mag 7 Pack7:15:26 AM ET

ANIK · NASDAQ

Anika Therapeutics, Inc.

$18.81 -0.52 (-2.69%)

Company overview

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc, which are indicated to provide pain relief from osteoarthritis conditions. Its joint preservation and restoration product family comprises a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products.

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Market cap
$252M
Employees
288
Headquarters
Bedford, MA
Website
anikatherapeutics.com
CEO
Stephen D. Griffin
Listed
May 3, 1993
P/E
-23.83
Dividend yield
0.00%

Company financials

Revenue
$116M
Gross profit
$68.1M
Operating income
-$12.3M
EBITDA
-$6.6M
Net income
-$11.1M
EPS
-$0.79
Total assets
$179M
Total debt
$25.7M
Gross margin
58.59%
Net margin
-9.52%
Earnings yield
-4.20%

Revenue segmentation

By product (FY 2025)

No annual product segmentation.

By region (FY 2025)

Reported on Mar 3, 2026

Showing FY 2025

Price chart

13.4115.8718.3320.7823.24
ANIK 1D NASDAQ O20.57H20.61L19.07C19.33-1.07 (-5.25%)Vol90.21K

News

LiveHeadlines show up as soon as they are ingested, with ticker, type, source, and time.

Pro

15-min delayYour Free plan is delayed 15 minutes. Pro opens the live desk.

Start 7-day free trial See live plans

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans

Since 2020This range is older than the last year on your plan. Pro opens articles since 2020.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
ANIKAnika Therapeutics, Inc. Stock news Anika Therapeutics Q3 revenue rises on commercial channel growth Reuters
ANIKAnika Therapeutics, Inc. Stock news BRIEF-Anika Therapeutics Q3 Revenue USD 30.594 Million Reuters
ANIKAnika Therapeutics, Inc. Press release Anika Reports Third Quarter 2026 Financial Results GlobeNewswire
ANIKAnika Therapeutics, Inc. Press release Anika to Issue Third Quarter 2026 Financial Results on Friday, November 6, 2026 GlobeNewswire
ANIKAnika Therapeutics, Inc. Stock news Is Anika Therapeutics (ANIK) Outperforming Other Medical Stocks This Year? Zacks Investment Research
ANIKAnika Therapeutics, Inc. Stock news Xencor (NASDAQ:XNCR) versus Anika Therapeutics (NASDAQ:ANIK) Head-To-Head Contrast Defense World
ANIKAnika Therapeutics, Inc. Stock news Best Momentum Stocks to Buy for August 26th Zacks Investment Research
ANIKAnika Therapeutics, Inc. Stock news Anika (ANIK) Is a Great Choice for 'Trend' Investors, Here's Why Zacks Investment Research
ANIKAnika Therapeutics, Inc. Stock news Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why? Zacks Investment Research
ANIKAnika Therapeutics, Inc. Stock news 5 Stocks With Recent Price Strength to Enhance Your Portfolio Returns Zacks Investment Research
ANIKAnika Therapeutics, Inc. Stock news Anika Therapeutics (ANIK) Is Up 11.10% in One Week: What You Should Know Zacks Investment Research
ANIKAnika Therapeutics, Inc. Stock news 5 Stocks With Recent Price Strength to Tap August Rally Zacks Investment Research
ANIKAnika Therapeutics, Inc. Stock news Anika (ANIK) is on the Move, Here's Why the Trend Could be Sustainable Zacks Investment Research
ANIKAnika Therapeutics, Inc. Press release Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026 GlobeNewswire
ANIKAnika Therapeutics, Inc. Stock news Bullish On Anika Therapeutics's Pullback As Integrity Scales Seeking Alpha
ANIKAnika Therapeutics, Inc. Stock news Anika Therapeutics, Inc. (ANIK) Q1 2026 Earnings Call Transcript Seeking Alpha
ANIKAnika Therapeutics, Inc. Press release Anika Reports First Quarter 2026 Financial Results GlobeNewswire
ANIKAnika Therapeutics, Inc. Press release Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026 GlobeNewswire
ANIKAnika Therapeutics, Inc. Stock news Is Anika Therapeutics Inc (ANIK) a Bargain After 3.1% Drop? GF Value Says Undervalued GuruFocus
ANIKAnika Therapeutics, Inc. Press release Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
See more
FAQ

Questions about Anika Therapeutics, Inc.

What does Anika Therapeutics, Inc. do?
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc, which are indicated to provide pain relief from osteoarthritis conditions. Its joint preservation and restoration product family comprises a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products.
What is ANIK's market cap?
Anika Therapeutics, Inc. (ANIK) is a listed stock with a live quote. The latest market cap on this page is $252M.
Where is Anika Therapeutics, Inc. headquartered?
Anika Therapeutics, Inc. is headquartered in Bedford, MA.
How do I get ANIK news from the API?
Call GET /v1/news?tickers=ANIK. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does ANIK news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for ANIK, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the ANIK price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs